Valerie Lee

Assistant Professor

20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Valerie Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Milk Thistle Medicine & Life Sciences
Programmed Cell Death 1 Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

Current Status of Immunotherapies for Treating Pancreatic Cancer

Wu, A. A., Jaffee, E. & Lee, V., Jul 1 2019, In : Current oncology reports. 21, 7, 60.

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Immunotherapy
Adenocarcinoma
Vaccines
Antigens

A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan

Lee, V., Wang, J., Zahurak, M., Gootjes, E., Verheul, H. M., Parkinson, R., Kerner, Z., Sharma, A., Rosner, G., De Jesus-Acosta, A., Laheru, D., Le, D., Oganesian, A., Lilly, E., Brown, T., Jones, P., Baylin, S. B., Ahuja, N. & Azad, N., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6160-6167 8 p.

Research output: Contribution to journalArticle

irinotecan
Colorectal Neoplasms
Intercellular Signaling Peptides and Proteins
Fever
Gastrointestinal Neoplasms

Role of liquid biopsies in colorectal cancer

Wills, B., Gorse, E. & Lee, V., Nov 1 2018, In : Current Problems in Cancer. 42, 6, p. 593-600 8 p.

Research output: Contribution to journalShort survey

Colorectal Neoplasms
Biopsy
Circulating Neoplastic Cells
Neoplasms
Drug Resistance

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer

Shrestha, B., Sun, Y., Faisal, F., Kim, V., Soares, K., Blair, A., Herman, J. M., Narang, A., Dholakia, A. S., Rosati, L., Hacker-Prietz, A., Chen, L., Laheru, D., De Jesus-Acosta, A., Le, D., Donehower, R. C., Azad, N., Diaz, L. A., Murphy, A., Lee, V. & 11 others, Fishman, E. K., Hruban, R. H., Liang, T., Cameron, J. L., Makary, M. A., Weiss, M. J., Ahuja, N., He, J., Wolfgang, C., Huang, C. Y. & Zheng, L., Jul 1 2017, In : Cancer Medicine. 6, 7, p. 1552-1562 11 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Drug Therapy
Neoadjuvant Therapy
Survival
Adenocarcinoma

Strategies for increasing pancreatic tumor immunogenicity

Johnson, B. A., Yarchoan, M., Lee, V., Laheru, D. & Jaffee, E., Apr 1 2017, In : Clinical Cancer Research. 23, 7, p. 1656-1669 14 p.

Research output: Contribution to journalReview article

Adenocarcinoma
Immunotherapy
Neoplasms
Drug Combinations
Standard of Care